TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
123
|
121 |
| Financial expenses |
0
|
9
|
0 |
| Earnings before taxes |
233
|
14
|
46 |
| EBITDA |
-54
|
18
|
28 |
| Total assets |
341
|
118
|
185 |
| Current assets |
38
|
52
|
131 |
| Current liabilities |
21
|
38
|
94 |
| Equity capital |
270
|
38
|
58 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.2%
|
32.2%
|
31.4% |
| Turnover per employee |
0
|
123
|
121 |
| Profit as a percentage of turnover |
11.4%
|
38.0% | |
| Return on assets (ROA) |
68.3%
|
19.5%
|
24.9% |
| Current ratio |
181.0%
|
136.8%
|
139.4% |
| Return on equity (ROE) |
86.3%
|
36.8%
|
79.3% |
| Change turnover |
-119
|
2
|
29 |
| Change turnover % |
-100%
|
2%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.